Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low vs High Dose Zonisamide Monotherapy in Children with Epilepsy
NCT01127165Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of zonisamide in epilepsy (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Percentage of Participants Who Were Assessed As Seizure Free at 24 weeks. Started Mar 2006; status: completed.
02
Drugs
zonisamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01127165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127165.